Burkett Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
MSV
VWM
SIS
QPBE
FFA
RT
WF
AAA
ACM
Burkett Financial Services's PFE Position: Q3 2026 in Review
Burkett Financial Services increased its Pfizer (PFE) stake by 1.5% in Q3 2026, buying an estimated $80 and bringing the position to 208 shares worth $5.94K. The position accounts for ﹤0.01% of the portfolio, ranked #319.
Burkett Financial Services first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. The position peaked at $97.6K in Q4 2023. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Burkett Financial Services held 208 shares of Pfizer worth $5.94K as of Q3 2026.
- Burkett Financial Services bought 3 Pfizer shares in Q3 2026, an estimated $80.
- Pfizer made up ﹤0.01% of Burkett Financial Services's portfolio in Q3 2026, its #319 holding.
- Burkett Financial Services first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
- Burkett Financial Services's Pfizer position peaked at $97.6K in Q4 2023.
- 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Burkett Financial Services's 13F filing for Q3 2026, filed 1 Oct 2026.